Mandrake Bio, a startup focused on the intersection of AI and structural biology, has secured $1.9M in a pre-seed funding round. The capital will fuel the company's efforts to accelerate the creation of de novo proteins.
The company's core mission involves harnessing the power of artificial intelligence alongside structural biology. This innovative approach is designed to unlock breakthroughs that can power a more sustainable, efficient, and resilient planet, leveraging advanced methods to engineer novel biological solutions.
.png&w=3840&q=75)
